---
title: "Royalty Pharma CFO Terrance P. Coyne sells USD 645,248 in common shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296146007.md"
description: "Royalty Pharma CFO Terrance P. Coyne sold 11,002 Class A ordinary shares on August 13 via TPC RP EPA1 LLC. The transaction averaged $58.59 for 9,230 shares and $59.14 for 1,772 shares, totaling approximately USD 645,248. Following this sale, TPC RP EPA1 LLC's stake in the company fell to zero shares."
datetime: "2026-08-17T21:02:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296146007.md)
  - [en](https://longbridge.com/en/news/296146007.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296146007.md)
generator: "portal-rs"
---

# Royalty Pharma CFO Terrance P. Coyne sells USD 645,248 in common shares

-   Royalty Pharma EVP and CFO Terrance P. Coyne sold 11,002 Class A ordinary shares on Aug. 13. \* Sales averaged USD 58.59 for 9,230 shares, then USD 59.14 for 1,772 shares, via TPC RP EPA1 LLC. \* TPC RP EPA1 LLC’s stake fell to zero shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001814876-26-000027), on August 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [RPRX.US](https://longbridge.com/en/quote/RPRX.US.md)

## Related News & Research

- [Royalty Pharma EVP and Chairman of Partnering Christopher Hite sells 100,000 shares for $6 million](https://longbridge.com/en/news/296396564.md)
- [Is Royalty Pharma (RPRX) Undervalued On Its $100 Million Zealand Pharma Royalty Deal?](https://longbridge.com/en/news/296647266.md)
- [Fleury board holding increases by R$ 70,053.75 after on-market share buy](https://longbridge.com/en/news/296728002.md)
- [Mark Brosius Sells 77 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock](https://longbridge.com/en/news/296661262.md)
- [Agilysys Insiders Sold Shares Worth Over $1.6M](https://longbridge.com/en/news/296401909.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**